Failure of blood pressure to increase following erythropoietin therapy in the renoprival status.
Two anephric patients in the course of one year erythropoietin therapy improved their anemic status without changes in Mean Arterial Blood Pressure. The discordant time course behaviour of hematocrit and blood pressure points to the importance of residual renal tissue for blood pressure to develop during erythropoietin therapy in the renoprival status.
De Santo
N G
NG
First Faculty of Medicine, University Federico II, Napoli, Italy.
Manzo
M
M
Raiola
P
P
Lanzetti
N
N
Capasso
G
G
Ficociello
R
R
Anastasio
P
P
Esposito
R
R
D000328:Adult; D000740:Anemia / Q000188:drug therapy / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects*; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D007668:Kidney / Q000502:physiology*; D008297:Male; D009392:Nephrectomy; D007690:Polycystic Kidney Diseases / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006435:Renal Dialysis / Q000009:adverse effects; D013997:Time Factors
D004921:Erythropoietin